At the 2023 World Congress on Gastrointestinal Cancers, Michael Pishvaian, MD, PhD, shared data from the first interim analysis of a phase 3 study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
RenovoRx Appoints Interventional Oncology Medtech Leader Richard Stark to its Board of Directors
RenovoRx today announced the appointment of Richard A. Stark, Chief Executive Officer of Innoblative Designs, Inc., to the Company’s Board of Directors.